Home > Compound List > Product Information
Dihydrocodeine_Molecular_structure_CAS_125-28-0)
Click picture or here to close

Dihydrocodeine

Catalog No. DB01551 Name DrugBank
CAS Number 125-28-0 Website http://www.ualberta.ca/
M. F. C18H23NO3 Telephone (780) 492-3111
M. W. 301.38012 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 1336

SYNONYMS

IUPAC name
(1S,5R,13R,14S,17R)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-ol
IUPAC Traditional name
dihydrocodeine

DATABASE IDS

PubChem CID 5284543
CAS Number 125-28-0
PubChem SID 46506478

PROPERTIES

DETAILS

Description (English)
Item Information
Drug Groups illicit; experimental
References
Rowell FJ, Seymour RA, Rawlins MD: Pharmacokinetics of intravenous and oral dihydrocodeine and its acid metabolites. Eur J Clin Pharmacol. 1983;25(3):419-24. [Pubmed]
Schmidt H, Vormfelde SV, Walchner-Bonjean M, Klinder K, Freudenthaler S, Gleiter CH, Gundert-Remy U, Skopp G, Aderjan R, Fuhr U: The role of active metabolites in dihydrocodeine effects. Int J Clin Pharmacol Ther. 2003 Mar;41(3):95-106. [Pubmed]
O'Neill WM, Hanks GW, Simpson P, Fallon MT, Jenkins E, Wesnes K: The cognitive and psychomotor effects of morphine in healthy subjects: a randomized controlled trial of repeated (four) oral doses of dextropropoxyphene, morphine, lorazepam and placebo. Pain. 2000 Mar;85(1-2):209-15. [Pubmed]
External Links
Wikipedia

REFERENCES

  • Rowell FJ, Seymour RA, Rawlins MD: Pharmacokinetics of intravenous and oral dihydrocodeine and its acid metabolites. Eur J Clin Pharmacol. 1983;25(3):419-24. Pubmed
  • Schmidt H, Vormfelde SV, Walchner-Bonjean M, Klinder K, Freudenthaler S, Gleiter CH, Gundert-Remy U, Skopp G, Aderjan R, Fuhr U: The role of active metabolites in dihydrocodeine effects. Int J Clin Pharmacol Ther. 2003 Mar;41(3):95-106. Pubmed
  • O'Neill WM, Hanks GW, Simpson P, Fallon MT, Jenkins E, Wesnes K: The cognitive and psychomotor effects of morphine in healthy subjects: a randomized controlled trial of repeated (four) oral doses of dextropropoxyphene, morphine, lorazepam and placebo. Pain. 2000 Mar;85(1-2):209-15. Pubmed